Patent classifications
A61J2205/30
Medicine cassette, medicine dispensing apparatus and medicine packaging apparatus
A medicine cassette 100 includes a side-wall constituent body 110, a first rotating body 120, a second rotating body 130 and a medicine discharging part 144c. The medicine cassette 100 can scrape up medicines prepared in a medicine containing part 182 along with a rotation of the first rotating body 120 to transfer and place the medicines onto the second rotating body 130 and transfer the medicines toward a downstream side of a rotational direction of the second rotating body 130 to discharge the medicines from the medicine discharging part 144c. An expanding portion 110a expanding toward an outer side of a radial direction of the second rotating body 130 is provided in the side-wall constituent body 110 on a lower side of the second rotating body 130.
System and method for the verification of medication
A system and method for verifying proper possession of a medication is disclosed. A reader device scans a code printed on the medication to extract an embedded serial number and captures an image of the face of the person in possession of the medication. A first server queries a prescription database, which retrieves facial characteristic data associated with the embedded serial number. A determination is made if the retrieved facial characteristic data matches facial characteristic data extracted from the captured image. The match information is displayed on the reader device.
ENZYMATIC LIGATION OF NUCLEIC ACIDS
Methods, assays, compositions and kits for the ligation of short polynucleotides are presented herein. The short polynucleotides are optionally no more than 7 nucleotides in length, and can be as short as 3 or 4 nucleotides in length. The ligation is optionally performed by CV ligase.
GENDER SPECIFIC PHARMACEUTICALS
The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes a pharmaceutical for use by a male and a first label coupled to the first package, wherein at least one of the first package and first label includes a male specifier and a recommended male dosage. The second package includes a pharmaceutical for use by a female and a second label coupled to the second package, wherein at least one of the second package and second label includes a female specifier and a recommended female dosage.
Tamper-evident label
A label includes (a) a base segment, (b) a first lobe segment comprising at least one protruding member and a pull tab, (c) a second lobe segment comprising at least one protruding member, (d) a first cutout segment, (e) a second cutout segment, (f) a first perforation forming a boundary between the base and first lobe segments, (g) a second perforation forming a boundary between the base and second lobe segments, and (h) a third perforation forming a boundary between the first lobe segment and its at least one protruding member. The first and second lobe segments are connected to the base segment and opposed to one another. The first and second cutout segments separate the at least one protruding member of the first and second lobe segments, respectively, from the base segment. The label comprises at least (A) a facesheet layer and (B) an adhesive layer.
Process for individually marking a medical product present under film or in a bag and marked product
A process for the marking of a film or a bag, which consists of a film at least in sections, wherein the film or the bag comprises a medical product or is provisioned or prepared for the uptake of such, wherein the process comprises connecting a film strip with, in, to and/or on the film, wherein the film strip carries information for marking the medical product.
Medical device case
This disclosure relates generally to embodiments disclosing a case designed to contain both a smartphone and a medical device, such as an epinephrine auto-injector. The case contains allows both the smartphone and the medical device to remain within the case while the case is being transported. The case may also include a release mechanism for releasing the medical device from the case.
Dispenser System And Methods For Medication Compliance
A medication dispensing system is provided and includes a medicine transfer device (MTD) and a controller. The MTD transfers medicine between first and second containers. The first container initially stores medicine. The controller: determines a first predetermined amount of medicine to be dispensed from the medicine dispensing system; causes the MTD to discharge a second predetermined amount of the medicine from the first container onto the MTD, and transfer a third predetermined amount of the medicine from the MTD to the second container; subsequent to the transfer of the third predetermined amount, determine whether the second container has greater than or equal to the first predetermined amount; and if the second container has less than the first predetermined amount, cause the MTD to transfer a portion of the medicine on the MTD into the second container or discharge a portion of the medicine in the first container onto the MTD.
PROTOCOL AND COMPOSITION FOR SUPPRESSION OF ALLERGIC RESPONSES
A protocol for limiting the severity of allergic reactions, or preventing them entirely, is provided. The central feature of the protocol is the delivery, over a period of no more than an ninety minutes, of an amount of magnesium ranging from 50-500 mg magnesium, measured as elemental magnesium. A wide variety of salts and chelates of magnesium may be used. The magnesium is deliver via IV, at a relatively high rate, of no more than ninety and preferably about thirty minutes. IV bags, prepared for use in this invention, reflecting the instructions for use set forth above, are claimed as well.
LOW MOLECULAR WEIGHT PECTIN COLUMN FOR APHERESIS
An apheresis column for the treatment of mammals to reduce galectin-3 levels is set forth. The column features, as a stationary or adsorbent phase, pectin molecules, which naturally bind gal-3. Modified citrus pectin, having a molecular weight of about 40 kD or less, preferably about 25 kD or less, is a preferred adsorbent. The columns are disposable, and are used in the fashion for apheresis in general. Other targets, particularly including other galectins, as well as toxins, heavy metals and the like may also be withdrawn from the blood or plasma through this method. Gal-3 level reductions of 10%, 30% and even more may be achieved in a single treatment.